In vivo experiments highlight that the consequences of MYCN oncogene inactivation are more dramatic in oncogene-addicted tumors, as observed in MYCN-amplified SK-N-BE(2) tumor-bearing mice. The gene discussed is MYCN; the disease is neoplasm.